Formulation industries run on molecular data: chromatograms, formulation histories, sensory profiles, process parameters, regulatory constraints. It is some of the most valuable technical knowledge in the world — and almost none of it behaves like a system. It sits fragmented across instruments, legacy software, spreadsheets, and the minds of a few experts.

The result is a paradox: industries that compete on innovation run R&D on fifteen-year-old infrastructure. Every new formula starts closer to zero than it should, and science advances in papers that never reach the bench. That is why generic AI keeps failing here: without structuring the evidence first — the spectrum, the trial, the context — no model converges.

Our research attacks the missing layer between the instrument and the question: structuring each company's experimental history — and only theirs — and turning what is lost today into training signal: every confirmation, rejection and correction an expert makes. On that foundation we adapt the state of the art — deconvolution, retention prediction, generative formulation, regulation as code — to each laboratory's real methods and products. Models never replace the expert: they order the evidence so experts decide better, and every decision teaches the system.

Our goal is simple to state and hard to build: to become the operating system for R&D in formulation industries. We started with the hardest data in the field. We are not stopping there.